[ad_1] Rapid success of first program leads to second collaboration to develop optimized enzyme for large scale manufacturing process Enzyme development expected to enable commercial-scale production of the API in 2025 SUNNYVALE, Calif., Sept. 18, […]

[ad_1] The agreement with Kalsec anticipates milestone payments for finalizing research and development work and a royalty stream for Willow upon commercialization SUNNYVALE, Calif., Sept. 5, 2024 /PRNewswire/ – Willow Biosciences Inc. (“Willow“) (TSX: WLLW) (OTCQB: CANSF), a […]